Prevention of venous thromboembolism following total hip replacement. Warfarin vs dextran 40.
D000328:Adult; D000367:Age Factors; D000368:Aged; D003911:Dextrans / Q000008:administration & dosage*; D005069:Evaluation Studies as Topic; D005260:Female; D006400:Hematocrit; D006615:Hip / Q000601:surgery*; D006621:Hip Joint; D006760:Hospitalization; D006801:Humans; D007273:Injections, Intramuscular; D007595:Joint Prosthesis; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D011446:Prospective Studies; D011517:Prothrombin Time; D012964:Sodium / Q000008:administration & dosage; D013924:Thrombophlebitis / Q000517:prevention & control*; D014859:Warfarin / Q000008:administration & dosage* / Q000009:adverse effects
D003911:Dextrans; D014859:Warfarin; D012964:Sodium